Therapeutic Goals in Patients with Refractory Chronic Angina

被引:9
作者
Cohen, Mauricio G. [1 ]
Pascual, Mario [1 ]
Scirica, Benjamin M. [2 ]
Ohman, E. Magnus [3 ]
机构
[1] Univ Miami, Fac Miller Med, Miami, FL USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Duke Univ, Ctr Med, Durham, NC USA
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2010年 / 63卷 / 05期
关键词
Angina pectoris; Coronary artery disease; Atherosclerosis; Quality of life; QUALITY-OF-LIFE; CORONARY-HEART-DISEASE; ENHANCED EXTERNAL COUNTERPULSATION; SECONDARY PREVENTION CLINICS; ARTERY-BYPASS-SURGERY; 3-YEAR FOLLOW-UP; I-F INHIBITOR; STABLE ANGINA; DOUBLE-BLIND; MYOCARDIAL-ISCHEMIA;
D O I
10.1016/S0300-8932(10)70119-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Refractory angina presents a major clinical challenge for everyday medical practice. Despite the widespread use of statins and improvements in revascularization techniques, a substantial proportion of patients with preserved left ventricular function and no life-threatening arrhythmias remain symptomatic, with severe debilitating angina. Because the rate of major cardiac events in this population is relatively low, the major aim of therapy should be not only to prolong survival but also to improve quality of life. The cornerstone of therapy for all these patients should be the aggressive modification of risk factors using evidence-based treatment, with the aim of stabilizing the disease process and improving overall survival. No opportunity for revascularization should be overlooked. Complementary approaches should be implemented to raise the angina threshold by either reducing oxygen demand or improving hemodynamics to increase myocardial oxygen supply. This review provides an update on therapeutic techniques and goals, and reinforces the need for a multidisciplinary approach to the management of patients with refractory angina.
引用
收藏
页码:571 / 582
页数:12
相关论文
共 58 条
[1]   The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes [J].
Arora, RR ;
Chou, TM ;
Jain, D ;
Fleishman, B ;
Crawford, L ;
McKiernan, T ;
Nesto, RW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1833-1840
[2]  
BENSON H, 1979, NEW ENGL J MED, V300, P1424
[3]   Optimal medical therapy with or without PCI for stable coronary disease [J].
Boden, William E. ;
O'Rourke, Robert A. ;
Teo, Koon K. ;
Hartigan, Pamela M. ;
Maron, David J. ;
Kostuk, William J. ;
Knudtson, Merril ;
Dada, Marcin ;
Casperson, Paul ;
Harris, Crystal L. ;
Chaitman, Bernard R. ;
Shaw, Leslee ;
Gosselin, Gilbert ;
Nawaz, Shah ;
Title, Lawrence M. ;
Gau, Gerald ;
Blaustein, Alvin S. ;
Booth, David C. ;
Bates, Eric R. ;
Spertus, John A. ;
Berman, Daniel S. ;
Mancini, G. B. John ;
Weintraub, William S. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Weintraub, W. ;
Maron, D. ;
Mancini, J. ;
Weintraub, W. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Knudtson, M. ;
Maron, D. ;
Bates, E. ;
Blaustein, A. ;
Booth, D. ;
Carere, R. ;
Ellis, S. ;
Gosselin, G. ;
Gau, G. ;
Jacobs, A. ;
King, S., III ;
Kostuk, W. ;
Harris, C. ;
Spertus, J. ;
Peduzzi, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1503-1516
[4]   Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial [J].
Borer, JS ;
Fox, K ;
Jaillon, P ;
Lerebours, G .
CIRCULATION, 2003, 107 (06) :817-823
[5]  
Borjesson M, 1997, CORONARY ARTERY DIS, V8, P543
[6]   Secondary prevention clinics for coronary heart disease: randomised trial of effect on health [J].
Campbell, NC ;
Thain, J ;
Deans, HG ;
Ritchie, LD ;
Rawles, JM ;
Squair, JL .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7142) :1434-1437
[7]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[8]  
Cavender MA, 2008, CIRCULATION, V118, pS853
[9]   Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina [J].
Chaitman, BR ;
Skettino, SL ;
Parker, JO ;
Hanley, P ;
Meluzin, J ;
Kuch, J ;
Pepine, CJ ;
Wang, W ;
Nelson, JJ ;
Hebert, DA ;
Wolff, AA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (08) :1375-1382
[10]   Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial [J].
Chaitman, BR ;
Pepine, CJ ;
Parker, JO ;
Skopal, J ;
Chumakova, G ;
Kuch, J ;
Wang, WD ;
Skettino, SL ;
Wolff, AA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (03) :309-316